News
New drugs - new decisions
Wednesday 24 September 2014
Target Ovarian Cancer are actively campaigning for greater participation in clinical trials so we are pleased to inform you that over the last six months five trials have opened looking at the potential benefits of a new class of drugs called PARP inhibitors. Early small clinical trials (Phase I/II...
Blog
Andrea and Jenny Prima Walk for One Million 2014
Wednesday 24 September 2014
Jenny and Andrea talk in this month’s Prima magazine about why Walk for One Million is so important: JENNY: There was a time when people didn’t talk about anything to do with your ‘tubes’. It was dismissed as ‘women’s problems’ and kept very hush-hush. Ovaries belonged in a biology lesson, not on a...
News
2014 BMA Patient Information Awards
Monday 22 September 2014
Target Ovarian Cancer is proud to announce that two of its vital resources have won awards in this year’s British Medical Association (BMA) Patient Information Awards: ‘Looking after me’ and the charity’s Clinical Trials Information Centre. Winning a 'Special award for user involvement', Target...
News
In the news: early diagnosis
Monday 22 September 2014
New analysis out today reveals that 46 per cent of cancers in England are diagnosed at an advanced stage, when they are harder to treat successfully. The Incisive Health report, commissioned by Cancer Research UK, estimates the cost of treating late stage colon, rectal, lung and ovarian cancer is...

Pages